Please login to the form below
Selincro
This page shows the latest Selincro news and features for those working in and with pharma, biotech and healthcare.
Acorda acquires Biotie to expand in Parkinson's disease
Biotie also has a royalty stream from Lundbeck's sales of Selincro(nalmefene), which was launched in 2013 for the treatment of alcohol dependency.
Latest news
-
Schultz takes Lundbeck helm after leaving Novo Nordisk
Newly launched alcohol dependency drug Selincro (nalmefene) added 41m kroner to the pot.
-
Brintellix first antidepressant with cognition claim in Europe
The Danish company also has a long-acting version of schizophrenia drug Abilify (aripiprazole) and alcohol addiction treatment Selincro (nalmefene) to help Brintellix return its revenues to growth.
-
NICE backs drug to cut alcohol consumption
NHS patients in England will now have access to Selincro (nalmefene), a once a day tablet marketed by Danish firm Lundbeck. ... Selincro has demonstrated its effectiveness in clinical trials where it has helped patients cut the amount they drink by an
-
Lundbeck still feeling effects from Cipralex patent loss
There were also gains for Lundbeck's new schizophrenia drug Abilify Maintena (aripiprazole) - although the company did not reveal figures - and the start of contributions from alcohol dependency treatment Selincro (nalmefene)
-
NICE recommends Lundbeck’s alcohol dependency drug
Lundbeck has high hopes for Selincro as it tries to overcome the impact of the loss of patent protection for its top selling treatment antidepressant Cipralex/Lexapro (escitalopram oxalate). ... The importance of new products like Selincro became even
More from news
Approximately 5 fully matching, plus 13 partially matching documents found.
Latest Intelligence
-
Pharma deals during September 2012
The companies already have a worldwide exclusive licence agreement from 2006 for Selincro (nalmefene), a novel opioid system modulator to treat alcohol dependence. ... Lundbeck filed a marketing authorisation application for Selincro in the EU with
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest appointments
-
CHC hires first full-time account director
Newman will help manage Clark Health Communications' business in women's health and alcohol dependence, which includes the Communiqué Award-winning campaign for Lundbeck's Selincro (nalmefene).
-
Bayer’s Barbara Jaszewski joins Lundbeck
Jaszewski's most pressing task will be to lead the launch of Selincro (nalmefene), which was recently recommended by the European Medicines Agency (EMA) to treat alcohol dependence.
-
Lundbeck promotes Andreas Eggert and Klaus Abel to senior commercial roles
vortioxetine for major depression and Selincro (nalmefene) for alcohol dependence.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Vice President, Medical Communications, UK, six figure package
-
Six figure salary
- Scientific Strategy Lead, Medical Communications, UK
-
Highly competitive salary
- Medical Writer, MRNA/ Covid 19, Medical Communications, UK
-
Highly competitive salary
- Bristol Myers Squibb announces positive trial results for treatment of MS
- Dermavant publishes positive phase 3 data for treatment of plaque psoriasis
- Enanta takes legal action against Pfizer over Paxlovid patent infringement
- Moderna to launch Innovation and Technology Center in the UK
- Biogen and Happify Health team up to create digital platform for MS patients
- Novartis and Precision BioSciences announce in vivo gene editing collaboration
- NICE issues final draft recommending Novartis’ Scemblix to treat chronic myeloid leukaemia
- Alzheimer's Research UK supports government plans for clinical research
- GSK announces The HealthTree Foundation’s multiple myeloma programme as first ‘Think Tank’ challenge winner
- NRG Therapeutics partners with Domainex to develop neurodegenerative disease treatment
- Innovative Trials opens first US office
- Scanning for Health Indicators and Risks Through Your Smartphone
- Research from Imperial College London shows single brain scan could diagnose Alzheimer’s disease
- VMLY&R wins two Grand Prix awards at Cannes Lions International Festival of Creativity 2022
- How digital health is changing the relationship between patients and health providers | OPEN Health
- Novartis endorses Kigali Declaration by investing $250m for tropical diseases
- Roche shares new positive Ocrevus data for MS patients
- Six UK universities receive grant for research into motor neurone disease
PMHub
Frontera Group
A leading global patient-activation group - comprising of a digital insight consultancy, creative activation agency. Our foundations lie in behavioural...
Latest intelligence
- Our Top 5 Pharma Picks From Cannes Lions
- Here are five of Art's top five pharma and healthcare picks from Cannes Lions 2022....
- The Evolving Role of the Sales Rep
- The COVID-19 pandemic sparked an evolution in physician engagement. Jill Padgett, EdD, Head of Training, explores what this means for the sales force and shares her advice for succeeding in...
- Measure your omnichannel maturity with our new tool
- Try our Omnichannel Maturity Tool to gain tangible advice and an instant analysis of your omnichannel readiness....
